CMO · CDMO · Technology Transfer
Non-Confidential Pharmaceutical Project Brief
A structured first-contact template for deciding whether a controlled technical discussion is appropriate - without sharing protected information prematurely.
Use this only for first contactInclude public or non-confidential context such as dosage form, presentation, target market, project stage, requested cooperation model and timing. Do not include patient information, full formulas, unpublished dossiers, manufacturing instructions, analytical methods or trade secrets before an NDA and controlled review plan are agreed.
Before detailed diligence
Download, complete and email the brief
Use the template to structure a limited first exchange. A reply or preliminary discussion does not create a commitment, price, capacity reservation, regulatory conclusion or product-fit determination.